Cardinal Health (CAH) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $1.93 per share a year ago.
Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Besides Wall Street's top-and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
CASY, CAH, EAT and FLS stand out with strong interest coverage ratios as investors seek stability in a tighter market.
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cardinal Health (CAH) reached $210.93 at the closing of the latest trading day, reflecting a +1.25% change compared to its last close.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.